{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-031375","form_type":"8-K","ticker":"CCCC","cik":"0001662579","company_name":"C4 Therapeutics, Inc.","filed_at":"2023-09-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.764447+00:00","generated_at":"2026-06-11T00:01:41.144044+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"C4 Therapeutics CFO Lauren White to step down; Kendra Adams named successor","bullets":["Lauren White resigns as CFO, Treasurer, and principal financial/accounting officer effective September 15, 2023; no disagreement cited.","Kendra Adams appointed CFO effective September 18, 2023; previously SVP, Communications and IR at C4T since Nov 2020.","Mark Mossler appointed Chief Accounting Officer and principal accounting officer effective Sept 18, 2023; previously VP, Corporate Controller since June 2023.","Adams receives $450K base salary, 40% bonus target, option for 111,000 shares, and 25,000 RSUs.","Mossler receives $315K base salary, 30% bonus target."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-031375","json":"https://secwatch.observer/filing/0001628280-23-031375.json","markdown":"https://secwatch.observer/filing/0001628280-23-031375.md","text":"https://secwatch.observer/filing/0001628280-23-031375.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1662579/000162828023031375/0001628280-23-031375-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1662579/000162828023031375/cccc-20230905.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T00:01:41.144044+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4419c1244c","claim":"Kendra Adams was appointed as Chief Financial Officer at C4 Therapeutics, Inc..","evidence_excerpt":"On September 5, 2023, the Company announced the appointment of Kendra Adams as its Chief Financial Officer, Treasurer and principal financial officer, effective as of Monday September 18, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1662579/000162828023031375/0001628280-23-031375-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"814a18a150","claim":"Mark Mossler was appointed as Chief Accounting Officer at C4 Therapeutics, Inc..","evidence_excerpt":"The Company has also appointed Mark Mossler as its Chief Accounting Officer and principal accounting officer, effective as of Monday September 18, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1662579/000162828023031375/0001628280-23-031375-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Accounting Officer"}],"fact_type":"executive_change"},{"claim_id":"9ab14e930a","claim":"Lauren White resigned as Chief Financial Officer at C4 Therapeutics, Inc..","evidence_excerpt":"On August 30, 2023, Lauren White informed us of her intent to resign from C4 Therapeutics, Inc. (the “ Company ”), effective as of Friday September 15, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1662579/000162828023031375/0001628280-23-031375-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}